HSBC WAR. CALL 06/24 SY1/ DE000HG3YGF4 /
30/05/2024 08:00:21 | Chg.-0.0300 | Bid08:49:34 | Demandez à08:49:34 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.8000EUR | -3.61% | 0.7400 Bid taille: 25,000 |
0.8000 Ask la taille: 25,000 |
SYMRISE AG INH. O.N. | 100.00 - | 19/06/2024 | Call |
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
08:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page